PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California-Reference-Cited by-同舟云学术

PD-1 inhibition therapy for advanced cutaneous squamous cell carcinoma: a retrospective analysis from the University of Southern California

Published:2020-11-18 Issue:6 Volume:147 Page:1803-1811
ISSN:0171-5216
Container-title:Journal of Cancer Research and Clinical Oncology
language:en
Short-container-title:J Cancer Res Clin Oncol

Author:

In Gino K.^ORCID,Vaidya Poorva,Filkins Alexandra,Hermel David J.,King Kevin G.,Ragab Omar,Tseng William W.,Swanson Mark,Kokot Niels,Lang Julie E.,Menendez Lawrence,DeClerck Brittney,Kim Gene,Hu Jenny C.,Terando Alicia,Jadvar Hossein,Ricker Charité,Miller Kimberly A.,Peng David H.,Wysong Ashley

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

https://link.springer.com/content/pdf/10.1007/s00432-020-03458-6.pdf

Reference39 articles.

1. Ansell SM, Lesokhin AM, Borrello I, Halwani A, Scott EC, Gutierrez M et al (2015) PD-1 blockade with nivolumab in relapsed or refractory Hodgkin’s lymphoma. N Engl J Med 372(4):311–319. https://doi.org/10.1056/NEJMoa1411087

2. Assam JH, Powell S, Spanos WC (2016) Unresectable cutaneous squamous cell carcinoma of the forehead with MLH1 mutation showing dramatic response to programmed cell death protein 1 inhibitor therapy. Clin Skin Cancer 1(1):26–29. https://doi.org/10.1016/j.clsc.2016.11.001

3. Brahmer J, Reckamp KL, Baas P, Crino L, Eberhardt WE, Poddubskaya E et al (2015) Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer. N Engl J Med 373(2):123–135. https://doi.org/10.1056/NEJMoa1504627

4. Brantsch KD, Meisner C, Schonfisch B, Trilling B, Wehner-Caroli J, Rocken M et al (2008) Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 9(8):713–720. https://doi.org/10.1016/s1470-2045(08)70178-5

5. Breuninger H, Brantsch K, Eigentler T, Hafner HM (2012) Comparison and evaluation of the current staging of cutaneous carcinomas. J Dtsch Dermatol Ges 10(8):579–586. https://doi.org/10.1111/j.1610-0387.2012.07896.x

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-World Experience With Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma;Journal of Cutaneous Medicine and Surgery;2024-07-26

2. Cutaneous Squamous Cell Carcinoma: An Updated Review;Cancers;2024-05-08

3. Personalized treatment concepts in extraocular cancer;Advances in Ophthalmology Practice and Research;2024-05

4. METTL3-mediated HPV vaccine enhances the effect of anti PD-1 immunotherapy to alleviate the development of cutaneous squamous cell carcinoma;Anais Brasileiros de Dermatologia;2023-11

5. Immune Checkpoint Inhibitors in Advanced Cutaneous Squamous Cell Carcinoma: Real-World Experience from a Canadian Comprehensive Cancer Centre;Cancers;2023-08-29